Precision Dosing in Children

作者: Daniel B Hawcutt , Lewis Cooney , Louise Oni , Munir Pirmohamed

DOI: 10.1080/23808993.2016.1138845

关键词: PediatricsMedicinePharmacokineticsObesityDosingIntensive care medicineOff-label usePharmacogenomicsWarfarinPharmacodynamicsPrecision medicine

摘要: ABSTRACTUnlike adult medicine, there are fewer choices of medicines per condition in children, and for existing medications, supporting data on pharmacokinetics, pharmacodynamics, or pharmacogenomics is often incomplete. Many pediatric doses calculated using body weight to produce a dose the individual child, but this not true personalisation as suggested (usually mg/kg) same large age range children. The challenge implementation precision medicine pediatrics therefore develop an appropriate evidence base (particularly unlicensed off label medications), then add onto it relevant genotype, environmental lifestyle guide both medication selection (where exist) required. This review will consider where consideration crucial pediatrics, including developmental changes across childhood, obesity, old new dosing scarce and/or inadequately extrapolated ...

参考文章(80)
Gilbert Ja, Aziz A, Roberts Kc, Shields M, de Groh M, Overweight and obesity in children and adolescents: results from the 2009 to 2011 Canadian Health Measures Survey. Health Reports. ,vol. 23, pp. 37- 41 ,(2012)
Katharina Schilbach, Martin Bidlingmaier, Growth hormone binding protein – Physiological and analytical aspects Best Practice & Research Clinical Endocrinology & Metabolism. ,vol. 29, pp. 671- 683 ,(2015) , 10.1016/J.BEEM.2015.06.004
Jennifer R. Bellis, Jamie J. Kirkham, Anthony J. Nunn, Munir Pirmohamed, Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital British Journal of Clinical Pharmacology. ,vol. 77, pp. 545- 553 ,(2014) , 10.1111/BCP.12222
M E Terry, G M Rourke, J D Crawford, Simplification of drug dosage calculation by application of the surface area principle. Pediatrics. ,vol. 5, pp. 783- 790 ,(1950)
Nigel Baber, Deborah Pritchard, Dose estimation for children. British Journal of Clinical Pharmacology. ,vol. 56, pp. 489- 493 ,(2003) , 10.1046/J.1365-2125.2003.01901.X
T N Johnson, The problems in scaling adult drug doses to children Archives of Disease in Childhood. ,vol. 93, pp. 207- 211 ,(2008) , 10.1136/ADC.2006.114835
Trevor N Johnson, Amin Rostami-Hodjegan, Geoffrey T Tucker, Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clinical Pharmacokinectics. ,vol. 45, pp. 931- 956 ,(2006) , 10.2165/00003088-200645090-00005
R. C. Dale, F. Brilot, L. V. Duffy, M. Twilt, A. T. Waldman, S. Narula, E. Muscal, K. Deiva, E. Andersen, M. R. Eyre, D. Eleftheriou, P. A. Brogan, R. Kneen, G. Alper, B. Anlar, E. Wassmer, K. Heineman, C. Hemingway, C. J. Riney, A. Kornberg, M. Tardieu, A. Stocco, B. Banwell, M. P. Gorman, S. M. Benseler, M. Lim, Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease Neurology. ,vol. 83, pp. 142- 150 ,(2014) , 10.1212/WNL.0000000000000570
Farzaneh Salem, Trevor N. Johnson, Khaled Abduljalil, Geoffrey T. Tucker, Amin Rostami-Hodjegan, A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data Clinical Pharmacokinectics. ,vol. 53, pp. 625- 636 ,(2014) , 10.1007/S40262-014-0140-7